Arquivos Brasileiros de Endocrinologia & Metabologia · 2011 · 50 citations · 13 references
PharmacyClinical PharmacyPharmacoeconomicsCost-effectiveness AnalysisPharmaceutical CareResource Utilization AnalysisDiabetes ControlDiabetes MellitusHealthcare Cost AnalysisMedication UsePharmaceutical EconomicsPharmacoeconomic EvaluationControl Group DesignDrug Cost AnalysisEconomic Performance EvaluationExperimental Study DesignGeneral CostsMatched Control GroupPrescription Drug CostsPrescription Drug Expenditures
OBJECTIVE: To analyze the costs related to visits and drug prescription in outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. SUBJECTS AND METHODS: A prospective and experimental study was carried out. Seventy one patients were divided into two groups: control and pharmaceutical care. Patients in the pharmaceutical care group were followed up monthly by a single clinical pharmacist. RESULTS: The pharmaceutical care group had a statistically significant reduction in costs of metformin and emergency department visits, and increased costs with their family physicians. On the other hand, the control group had a statistically significant increase of 21.3% in the general costs of treatment and visits. CONCLUSION: The pharmaceutical care group maintained the same costs related to drugs and visits, while the control group showed a significant increase in general costs.
13
Potential Short-Term Economic Benefits of Improved Glycemic Control
Joseph Menzin, Clare Langley-Hawthorne, Mark Friedman et al. · Diabetes Care · 2001 · 177 citations · Full text